Sun Pharma included in S&P Global Sustainability Yearbook 2024

12 Feb 2024 Evaluate

Sun Pharmaceutical Industries has been included in the S&P Global Sustainability Yearbook 2024. Within respective industries, this Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability.

This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses. Based on the S&P Global Corporate Sustainability Assessment (CSA) for 2023, over 9,400 companies were assessed for The Sustainability Yearbook 2024. Out of these, 739 companies have qualified for inclusion in The Sustainability Yearbook 2024 globally. 

Sun Pharmaceutical Industries is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×